Sichuan Biokin Pharmaceutical Co Ltd (688506) Stock Price & News

688506:SHA

Sichuan Biokin Pharmaceutical Co Ltd

CN¥233.88

+1.17%

(+2.71) 1D

Oct 16, 3:00:01 PM GMT+8 · CNY

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 688506...

Open

CN¥233.33

High

CN¥242.99

Low

CN¥230.10

Mkt. cap

93.56B

Avg. vol.

1.57M

Volume

1.83M

52-wk high

CN¥404.00

52-wk low

CN¥200.10

EPS

-CN¥3.79

No. of employees

Open

CN¥233.33

High

CN¥242.99

Low

CN¥230.10

Mkt. cap

93.56B

Avg. vol.

1.57M

Volume

1.83M

52-wk high

CN¥404.00

52-wk low

CN¥200.10

EPS

-CN¥3.79

No. of employees

Related stocks

Beijing Wantai Biolog Pha Ent Co Ltd

CN¥25.04

-1.03%

600276

Jiangsu Hengrui Pharmaceuticals Co Ltd

CN¥46.63

+0.06%

688271

Shanghai United Img Hlthcare Co Ltd

CN¥108.04

+0.59%

News stories

From web sources and news partners

TradingView

35 minutes ago

US Stocks Fall as Chip Selloff Deepens

Investing.com

12 minutes ago

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.34%

Yahoo Finance

49 minutes ago

Skydance On Track To Be The Week's Worst-Performing S&P 500 Stock: Bernstein SocGen Halves Price Target On Cash Flow Uncertainty

StoneX

5 hours ago

S&P 500 Forecast: SPX set for a weekly decline led lower by tech as AI worries linger

Profile

Sichuan Biokin Pharmaceutical Co., Ltd. is a publicly listed Chinese biopharmaceutical company that is headquartered in Chengdu, Sichuan. Wikipedia

About Sichuan Biokin Pharmaceutical Co Ltd

CEO-

Employees3.43K

FoundedAug 23, 1996

Headquarters-

SectorPharmaceutical industry

Websiteen.baili-pharm.com

All values in CNY	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	1.89B	454.22M	94.59M	92.75M
Cost of goods sold	43.74M	115.66M	43.37M	59.34M
Cost of revenue	43.74M	115.66M	43.37M	59.34M
Research and development expenses	733.75M	741.34M	694.76M	787.93M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	144.15M	169.94M	126.35M	113.01M
Operating expense	862.71M	926.05M	813.01M	892.42M
Total operating expenses	906.45M	1.04B	856.38M	951.76M
Operating income	988.25M	-587.49M	-761.79M	-859.01M
Other non operating income	-68.11M	68.05M	-142.74M	142.75M
EBT including unusual items	942.32M	-535.84M	-776.15M	-901.42M
EBT excluding unusual items	977.50M	-586.93M	-841.61M	-965.12M
Income tax expense	318.88M	23.26M	-1.59M	-38.76M
Effective tax rate	33.84%	-4.34%	0.21%	4.30%
Other operating expenses	-15.12M	14.55M	-7.43M	-9.01M
Net income	623.44M	-559.10M	-774.56M	-862.66M
Net profit margin	32.90%	-123.09%	-818.89%	-930.11%
Earnings per share	-	-	-	-
Interest and investment income	54.03M	56.43M	89.48M	36.67M
Interest expense	-24.43M	-26.18M	-26.56M	-29.06M
Net interest expenses	29.60M	30.26M	62.92M	7.62M
Depreciation and amortization charges	-	-	-	-
EBITDA	1.01B	-567.21M	-741.51M	-836.43M
Gain or loss from assets sale	1.06K	-1.06K	-	-

Ask anything